长风药业股份有限公司（02652）于2026年5月7日公告，当日于香港联交所回购10,500股H股股份，约占回购前已发行股本的0.0035%。该公司此次回购股份的最高价格为每股21.86港元、最低价格为每股21.60港元，共动用资金约22.80万港元。
回购完成后，公司已发行股份总数保持为302,223,586股，其中已发行股份（不包括库存股份）为301,536,086股，库存股份为687,500股。公司回购授权于2025年12月16日获得通过，授权总数为30,222,358股，至今已回购股份数目达687,500股，占授权通过时已发行股本约0.2275%。根据公告，本次回购后，公司将遵守有关购回后30日暂止期的相关规定，暂止期至2026年6月6日。
公司表示，本次回购行为已严格遵守香港联合交易所有限公司证券上市规则及相关法律法规，并由董事会正式授权。公告由公司执行董事及联席公司秘书朱玉玉签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.